June 29, 2012

Boston Business Journal

Executive Profile: Jill Milne

Jill Milne's lifetime love of science

One of the best decisions Catabasis Pharmaceuticals CEO Jill Milne ever made, she made when she was 15 years old. She signed up for an educational summer camp that helped solidify an already growing passion for science. The fact that she also met her husband, Ironwood Pharmaceuticals   (Nasdaq: IRWD) co-founder Todd Milne, among the beakers and dissected frogs, was a bonus.
 
“My parents had always encouraged me to pursue science, and I also had a middle school teacher, who ran an oceanography class, who really had a gift for capturing our imaginations.”
 
Milne had grown up around the pharmaceutical industry; her father worked for Pfizer in Waterford, Conn., as a chemical operator, and it was Pfizer where she would initially land after completing her doctorate at Harvard in 1995. After several years at Pfizer, here in Massachusetts, she rose to be the head of a small business development group. It was then that Polaris Venture Partners knocked on her door. There she helped launch Sirtis Pharmaceuticals, where she worked until it was acquired in 2008 for $720 million by GlaxoSmithKline (NYSE: GSK).
 
Excerpt from Boston Business Journal.  For full article, visit:  http://www.bizjournals.com/boston/print-edition/2012/06/29/executive-profile---jill-milne.html

by Julie M. Donnelly